| Course | N511 Advanced Pharmacology |
|---|---|
| Module | Module 7 |
| Paper type | Focused exam reflection |
| Length | About 507 words, 4 pages |
| Format | APA 7 student paper |
| School | Aspen University |
| Program | MSN |
| Updated | October 2026 |
Free sample paper for N511 Module 7
Two Bronchodilators in One Device She Can Actually Use: Reflecting on COPD Maintenance Therapy for a 67-Year-Old With Arthritic Hands
Student Name
Master of Science in Nursing Program, Aspen University
N511: Advanced Pharmacology
Instructor Name
Month Day, Year
Two Bronchodilators in One Device She Can Actually Use: Reflecting on COPD Maintenance Therapy for a 67-Year-Old With Arthritic Hands
The digital patient in this module's ShadowHealth COPD exam, a composite for this essay, is a 67-year-old retired seamstress with COPD who uses only an albuterol inhaler, now four to five times a day. She has a modified Medical Research Council dyspnea grade of 2, a COPD Assessment Test score of 18, and one exacerbation treated at home with prednisone last winter. Her blood eosinophil count is 150 cells/µL, and she has rheumatoid arthritis affecting her hands. This essay reflects on my exam and answers the module's prompts.
Reflection and Selection Rationale
I took a thorough respiratory history but did not ask her to show me how she uses her inhaler until the exam prompted it. When she did, she exhaled into the mouthpiece and did not hold her breath. Poor technique is common: a systematic review found that only about a third of patients used their inhalers correctly (Sanchis et al., 2016).
Her symptoms are high and she has had one moderate exacerbation without hospitalization, which places her in GOLD group B. The 2023 GOLD report recommends a combination of a long-acting muscarinic antagonist and a long-acting beta-2 agonist for this group, and reserves an inhaled corticosteroid for patients with frequent exacerbations and blood eosinophils of 300 cells/µL or more (Agustí et al., 2023). With an eosinophil count of 150, she would not benefit enough from a corticosteroid to justify its pneumonia risk. I would prescribe tiotropium/olodaterol by soft mist inhaler, two puffs once daily, and keep albuterol for rescue. The soft mist device releases a slow aerosol that does not require a forceful inhalation, and it can be fitted with a loading aid for weak hands. The best drug fails in a device the patient cannot operate.
Monitoring, Adverse Effects, and Education
I would reassess her in four to six weeks: rescue inhaler use, CAT score, and inhaler technique observed directly. Tiotropium's anticholinergic action commonly dries the mouth and, less often, can precipitate urinary retention or aggravate narrow-angle glaucoma; olodaterol can cause tremor and palpitations. She should avoid adding other anticholinergic drugs, such as over-the-counter sleep aids containing diphenhydramine.
Teaching would cover once-daily timing, a demonstration with teach-back, rinsing and cleaning the device, and a written action plan for flares. Nonpharmacologic measures matter as much: pulmonary rehabilitation, influenza and pneumococcal vaccination, and staying tobacco-free (Agustí et al., 2023). Respiratory syncytial virus is now preventable as well: the 2023 federal recommendation allowed adults aged 60 and older to receive a single vaccine dose through shared clinical decision-making, with chronic lung disease named among the conditions that raise the risk of severe illness (Melgar et al., 2023). For her, that conversation belongs at the same visit.
Looking Ahead
From now on I will watch the patient use the inhaler before changing the drug in it. Her rising albuterol use reflected both undertreatment and poor technique, and only one of those problems could be solved with a prescription.
References
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., Mortimer, K., Papi, A., Pavord, I., Roche, N., Salvi, S., Sin, D. D., Singh, D., Stockley, R., López Varela, M. V., ... Vogelmeier, C. F. (2023). Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD executive summary. European Respiratory Journal, 61(4), Article 2300239. https://doi.org/10.1183/13993003.00239-2023
Melgar, M., Britton, A., Roper, L. E., Talbot, H. K., Long, S. S., Kotton, C. N., & Havers, F. P. (2023). Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR. Morbidity and Mortality Weekly Report, 72(29), 793-801. https://doi.org/10.15585/mmwr.mm7229a4
Sanchis, J., Gich, I., & Pedersen, S. (2016). Systematic review of errors in inhaler use: Has patient technique improved over time? Chest, 150(2), 394-406. https://doi.org/10.1016/j.chest.2016.03.041
What the N511 Module 7 instructions ask for
Aspen's N511 Module 7 pairs a ShadowHealth COPD focused exam with a reflection of about 500 words, in APA with two or more scholarly sources, reviewing how the exam went and what you would prescribe. Each sentence has to work. Name what you did well and what you missed, especially about inhaler technique. Place the patient in a GOLD group with the data that put her there. Choose maintenance therapy and the device, and explain both. Address when an inhaled corticosteroid would or would not be added. Plan monitoring, adverse effects and teaching, including how you will check technique. Mention vaccinations. End with the habit you will keep, and make sure the device you choose fits the patient's hands, eyesight and breathing strength.
Inside the N511 Module 7 example
The opening lists the case data: albuterol four to five times a day, a dyspnea grade of 2, a CAT score of 18, one home-treated exacerbation, eosinophils of 150 and rheumatoid arthritis in her hands. The reflection admits the writer did not watch her use the inhaler until prompted, then describes her exhaling into the mouthpiece and skipping the breath hold, with Sanchis's finding that only about a third of patients use inhalers correctly. Group B leads to a combination of tiotropium and olodaterol in one soft mist device that needs little hand strength. An inhaled corticosteroid is not added because her eosinophils are low. Monitoring at four to six weeks, dry mouth and urinary retention risks, teach-back and vaccinations follow. The final line commits to watching technique before changing drugs.
N511 Module 7 rubric: what earns full marks
The heaviest weight in this reflection sits on matching the drug and the device to the patient. GOLD grouping is shown with the data behind it, so the grader can check it. The device choice is justified by her hands, which is the insight of the case. The decision not to add an inhaled corticosteroid is explained with her eosinophil count. Monitoring includes observed technique. Adverse effects are specific to each drug. Agustí's 2023 GOLD summary, Melgar's 2023 MMWR report on RSV vaccines and Sanchis's 2016 Chest review are the APA 7 sources. At about 500 words, the essay answers every prompt and still leaves room for an honest admission, which is what makes it a reflection.
Common N511 Module 7 mistakes, and how to avoid them
COPD reflections often choose the right drug class and ignore the device. Ask whether the patient can use it. Another gap is assigning a GOLD group without showing the symptom score and exacerbation history that place her there. Students also add an inhaled corticosteroid by habit; explain when the guideline supports it. Monitoring should include watching technique, not only asking about symptoms. Adverse effects should be specific, such as dry mouth and urinary retention for an anticholinergic. Teaching needs teach-back, not just a handout. Mention vaccines. Keep the essay near 500 words. Finally, cite the current GOLD report, since recommendations for initial therapy changed in recent years.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More N511 and MSN sample papers
- N511 Module 1: Shadow Health Reflection
- N511 Module 2: UTI Focused Exam Reflection
- N511 Module 3: Antihypertensive Reflection
- N511 Module 4: Pneumonia Focused Exam Reflection
- N511 Module 5: Drug Therapy Paper
- N511 Module 6: Pain Management Reflection
- N511 Module 8: Focused Exams Medication Review
- N538 Module 5: EHR Safety Problem
- N522 Module 6: Planned Change
- N510 Module 4: Cancer Pathophysiology Case
- N520 Module 3: Liability Insurance Case Responses
N511 Module 7 questions, answered
What does N511 Module 7 usually ask for?
A ShadowHealth COPD focused exam and a reflection essay of about 500 words in APA with at least two scholarly sources, covering your prescribing choice, alternatives, monitoring, adverse effects, interactions and education.
What does GOLD recommend for group B COPD?
The 2023 GOLD report recommends a combination of a long-acting muscarinic antagonist and a long-acting beta-2 agonist for patients with high symptoms and no more than one moderate exacerbation without hospitalization.
When is an inhaled corticosteroid added in COPD?
GOLD reserves it mainly for patients with frequent or severe exacerbations and blood eosinophils of 300 cells/µL or more, because the benefit is small at lower counts and inhaled corticosteroids raise pneumonia risk.
Where can I find a free N511 Module 7 sample paper?
The complete N511 Module 7 COPD reflection is printed above, choosing a combined bronchodilator in an inhaler suited to a patient with arthritic hands.
What inhaler mistake does the N511 Module 7 reflection catch?
The patient exhaled into the mouthpiece and skipped the breath hold, which the writer noticed only after watching her use it. Sanchis's review found only about a third of patients use inhalers correctly.